A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs

Biyu Shen1,2, Songsong Shi1, Hengmei Cui1

  • 1Department of Nursing, Shanghai Children's Medical Center, Shanghai, China.

Insights

This study investigates electronic patient-reported outcome (ePRO) symptom management for juvenile idiopathic arthritis (JIA) in children. Findings suggest ePROs improve JIA symptom management and monitoring, offering a feasible intervention.

Area of Science:

  • Pediatric Rheumatology
  • Digital Health
  • Clinical Trial Methodology

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic rheumatic disease in children under 16.
  • Patient-reported outcomes (PROs) are crucial for evaluating JIA impact and treatments.
  • Challenges exist in pediatric PRO implementation and ePROs for JIA symptom management remain understudied.

Purpose of the Study:

  • To evaluate the effect and usability of electronic PROs (ePROs) for symptom management in children with JIA.
  • To compare individualized ePRO-based management with routine care.
  • To assess PROs and health-related quality of life (HRQOL) over 12 months.

Main Methods:

  • A longitudinal, randomized controlled trial involving 100 children with JIA.
  • Participants were randomized to ePRO-based symptom management or routine management.
  • Data collected at baseline and 1, 3, 6, and 12 months, focusing on C-Ped-PROMIS T-scores and HRQOL.

Main Results:

  • The study is expected to demonstrate improved JIA symptom management in the ePRO group.
  • ePRO-based management is anticipated to be a feasible and effective monitoring tool.
  • The relationship between C-Ped-PROMIS T-scores and HRQOL will be analyzed.

Conclusions:

  • Symptom management based on ePROs is expected to enhance outcomes for children with JIA.
  • ePROs offer a viable and effective approach for monitoring and intervening in pediatric JIA.
  • This study provides evidence for the utility of digital health tools in pediatric rheumatology.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
29
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
554
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
34
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K